Second-line, low-dose, weekly paclitaxel in patients with stage IIIB/IV nonsmall cell lung carcinoma who fail first-line chemotherapy with carboplatin plus paclitaxel
Mark A. Socinski, Michael J. Schell, Kamal Bakri, Amy Peterman, Ji-Hyun Lee, Paul Unger, Steven Yates, Stacie Hudgens, Merrill S. KiesVolume:
95
Year:
2002
Language:
english
Pages:
9
DOI:
10.1002/cncr.10835
File:
PDF, 83 KB
english, 2002